RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
Rochester, MN · +11 more sites
Prostate Cancer clinical trials in Rochester, MN
12 recruiting prostate cancer studies with a site in Rochester, MN.
RecruitingNot applicableNCT06325046
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Sponsor: Mayo Clinic
Albert Lea, MN · Mankato, MN · Rochester, MN · +2 more sites
RecruitingNot applicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sponsor: Axonics, Inc.
Rochester, MN · +22 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Minneapolis, MN · Rochester, MN · +29 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Rochester, MN · +28 more sites
RecruitingPhase 2NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Sponsor: Mayo Clinic
Rochester, MN · +2 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Rochester, MN · +23 more sites
RecruitingPhase not listedNCT04797039
MRI-Guided Cryoablation for Focal Native Prostate Cancer
Sponsor: Mayo Clinic
Rochester, MN
RecruitingPhase not listedNCT06315595
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
Sponsor: Mayo Clinic
Rochester, MN · +1 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Rochester, MN · +13 more sites
RecruitingNot applicableNCT04550845
Understanding of Genetics by Men at Risk for Prostate Cancer
Sponsor: Mayo Clinic
Rochester, MN · +2 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Rochester, MN · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.